the growing importance of celmods in the treatment of r/r multiple myeloma
Published 1 year ago • 188 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
0:52
the importance of incorporating frailty assessment tools in clinical practice for multiple myeloma
-
2:09
integrating novel agents into the treatment of multiple myeloma
-
1:40
vulnerabilities in lipid synthesis pathways and resistance to imids and celmods in multiple myeloma
-
2:03
activating the immune system with celmods to treat multiple myeloma
-
2:48
bortezomib maintenance with dex post-transplant for high-risk myeloma
-
21:38
drawing the line: the rationale behind blood tube collection order
-
58:27
laboratory nonconformance (event) management
-
9:25
mgus diagnosis: a step-by-step approach
-
2:44
myeloma qol through induction and maintenance
-
2:11
synergistic activity of alnuctamab and celmods in multiple myeloma preclinical models
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
6:42
myeloma: honing the immune system, building the armamentarium
-
1:53
the future of multiple myeloma treatment
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
6:32
cc-92480: a novel celmod, in r/r myeloma
-
2:07
challenges associated with the management of extramedullary myeloma & ongoing research
-
9:31
utilizing new understanding in multiple myeloma biology to guide treatment
-
2:31
selinexor in the myeloma treatment landscape and managing associated side effects
-
3:34
maintenance therapy following salvage asct for multiple myeloma
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
2:20
treatment sequencing in multiple myeloma: a multitude of options